| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |